Peer Review reports
From: Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial
| Original Submission | ||
|---|---|---|
| 18 Mar 2021 | Submitted | Original manuscript |
| 6 Apr 2021 | Reviewed | Reviewer Report |
| 22 Jun 2021 | Reviewed | Reviewer Report |
| 3 Aug 2021 | Author responded | Author comments - Masataka Tanimoto |
| Resubmission - Version 2 | ||
| 3 Aug 2021 | Submitted | Manuscript version 2 |
| 30 Aug 2021 | Author responded | Author comments - Masataka Tanimoto |
| Resubmission - Version 3 | ||
| 30 Aug 2021 | Submitted | Manuscript version 3 |
| Publishing | ||
| 8 Sep 2021 | Editorially accepted | |
| 28 Oct 2021 | Article published | 10.1186/s12905-021-01475-2 |
You can find further information about peer review here.